TBPH
Theravance Biopharma, Inc.
stockNASDAQ

Latest News

Oct 19, 2026

09:17 AM EDTZymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma · BNN Bloomberg

Sep 28, 2026

06:02 AM EDTZymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition · Financial Post

Sep 23, 2026

04:05 PM EDTZymeworks Completes Acquisition of Theravance Biopharma · Financial Post

Sep 18, 2026

05:40 PM EDTTheravance Biopharma shareholders approve merger with Zymeworks · Investing.com

Sep 17, 2026

06:19 PM EDTTheravance Biopharma SVP Rhonda Farnum sells $226k in stock · Investing.com

theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.